#VisualAbstract: Inavolisib Increased Overall Survival in PIK3CA-Mutated Advanced Breast Cancer

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc.Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

#VisualAbstract: Inavolisib Increased Overall Survival in PIK3CA-Mutated Advanced Breast Cancer

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

Ustekinumab may be superior to Vedolizumab for the treatment of Crohn’s disease

RelatedReports

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

Television CPR scripts undercut bystander response in real emergencies

#VisualAbstract: Vepdegestrant Increased Progres-sion-Free Survival in Advaced Breast 2m TM Cancer with ESR1 Mutations

Ustekinumab may be superior to Vedolizumab for the treatment of Crohn's disease

Cervical medial branch blocks may offer therapeutic benefit for facet-mediated neck pain

Antiseizure medications do not reduce the risk of epilepsy in patients with brain abscess

2MM+ All Access

Look up any US clinician

Recent Reports

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits